Meng‐Feng Tsai
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Co-authors
- Pan‐Chyr YangJin‐Yuan ShihJames Chih‐Hsin YangShang‐Gin WuChong‐Jen YuYih‐Leong ChangJeremy J.W. ChenTzu‐Hua Chang
- Topics
- Lung Cancer Treatments and Mutations (17 papers)Cancer Cells and Metastasis (6 papers)Lung Cancer Diagnosis and Treatment (6 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Meng‐Feng Tsai
55 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 118
- Pulmonary and Respiratory Medicine 900
- Oncology 856
- Molecular Biology 746
- Cancer Research 447
- Immunology 290
Countries citing papers authored by Meng‐Feng Tsai
This map shows the geographic impact of Meng‐Feng Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Feng Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Feng Tsai more than expected).
Fields of papers citing papers by Meng‐Feng Tsai
This network shows the impact of papers produced by Meng‐Feng Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Feng Tsai. The network helps show where Meng‐Feng Tsai may publish in the future.
Co-authorship network of co-authors of Meng‐Feng Tsai
This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Feng Tsai. A scholar is included among the top collaborators of Meng‐Feng Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Feng Tsai. Meng‐Feng Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 12 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 38 | |
| 7 | 27 | |
| 8 | 16 | |
| 9 | 66 | |
| 10 | 20 | |
| 11 | 2 | |
| 12 | 79 | |
| 13 | 129 | |
| 14 | 31 | |
| 15 | 80 | |
| 16 | 43 | |
| 17 | 57 | |
| 18 | 189 | |
| 19 | 22 | |
| 20 | 44 |
About Meng‐Feng Tsai
Meng‐Feng Tsai is a scholar working on Hardware and Architecture, Oncology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Cancer Cells and Metastasis (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (856 citations), Cancer Research (447 citations) and Pulmonary and Respiratory Medicine (900 citations). Meng‐Feng Tsai has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Pan‐Chyr Yang, Jin‐Yuan Shih, James Chih‐Hsin Yang, Shang‐Gin Wu, Chong‐Jen Yu, Yih‐Leong Chang, Jeremy J.W. Chen, Tzu‐Hua Chang, Pei‐Li Yao and Yinan Liu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.